IA + IO PRP vs IA Alone for Knee OA: Single-Blind RCT
Barman A · Injury (2022)
DOI: 10.1016/j.injury.2022.01.012This single-blind RCT explored the emerging concept of combined intra-articular (IA) plus intra-osseous (IO) PRP injection versus standard intra-articular PRP alone for knee OA. The rationale is that subchondral bone pathology is a major pain generator in OA, and targeting both the joint space and the underlying bone may produce superior outcomes. This represents a frontier approach in PRP delivery methodology.
Clinical Relevance
An innovative approach that may improve PRP outcomes for knee OA by targeting subchondral bone pathology. Currently experimental, but clinicians performing bone marrow procedures already have the technical skill set. Watch this space for future evidence.
Key Takeaways
- Novel approach targeting both joint space AND subchondral bone
- Subchondral bone is increasingly recognized as a key pain generator in OA
- Combined IO+IA injection is a conceptually promising but early-stage technique
- Preliminary data suggest possible additional benefit from IO injection
- Requires further validation in larger trials
- Represents the future direction of precision PRP delivery
Key Findings
Emerging approach targeting subchondral bone. Combined IO+IA may provide additional benefit. Larger trials needed.
Clinical Context
Study Design
Randomized Clinical Trial (Single-Blind)
Condition
Knee Osteoarthritis (IA + Intraosseous)
Control Group
Intra-articular PRP alone
Primary Outcome
WOMAC, VAS
PRP Protocol & Intervention
Injection Frequency
1 injection(s)
Guidance Method
Intra-articular +/- intra-osseous